ASND logo

Ascendis Pharma A/S (ASND) Selling, General & Administrative Expenses

Annual SGA

$307.98 M
+$27.81 M+9.93%

December 31, 2024

Summary

Performance

1-Year Change

+9.93%

3-Year Change

+62.5%

5-Year Change

+467.54%

15-Year Change

+1917.08%

ASND SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.95%
ASND annual SGA is higher than 85.95% of companies in Healthcare sector

High & Low

All-time High

$307.98 M
ASND annual SGA is currently at an all-time high

3-Year Low

$189.52 M
ASND annual SGA is currently +62.50% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ASND previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ASND next annual earnings announcement has not yet been scheduled

OtherASNDexpensesmetrics:

Annual Total Expenses

$695.31 M
ASND annual total expenses is $695.31 million

Annual Operating Expenses

$647.40 M
ASND annual total operating expenses is $647.40 million

Annual Cost Of Goods Sold

$47.90 M
ASND annual cost of goods sold is $47.90 million

Annual Interest Expense

$70.90 M
ASND annual interest expense is $70.90 million

Quarterly SGA

$83.98 M
+$9.05 M+12.08%

December 31, 2024

Summary

Performance

3-Month Change

+12.08%

1-Year Change

+4.95%

3-Year Change

+4.95%

5-Year Change

+4.95%

ASND Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.71%
ASND quarterly SGA is higher than 85.71% of companies in Healthcare sector

High & Low

All-time High

$83.98 M
ASND quarterly SGA is currently at an all-time high

3-Year Low

$52.33 M
ASND quarterly SGA is currently +60.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ASND previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ASND next earnings announcement is scheduled for May 2, 2025

OtherASNDexpensesmetrics:

Quarterly Total Expenses

$184.98 M
ASND quarterly total expenses is $184.98 million

Quarterly Operating Expenses

$170.03 M
ASND quarterly total operating expenses is $170.03 million

Quarterly Cost Of Goods Sold

$14.95 M
ASND quarterly cost of goods sold is $14.95 million

Quarterly Interest Expense

-$5.31 M
ASND quarterly interest expense is -$5.31 million

TTM SGA

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ASND TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$556.61 M
ASND TTM SGA is currently at an all-time high

3-Year Low

-$2.85 B
ASND TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ASND previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
ASND next earnings announcement is scheduled for May 2, 2025

OtherASNDexpensesmetrics:

Annual Total Expenses

$695.31 M
ASND annual total expenses is $695.31 million

Annual Operating Expenses

$647.40 M
ASND annual total operating expenses is $647.40 million

TTM Cost Of Goods Sold

$47.83 M
ASND TTM cost of goods sold is $47.83 million

TTM Interest Expense

$127.51 M
ASND TTM interest expense is $127.51 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$307.98 M
ASND annual SGA is $307.98 million

Annual Operating Expenses

$647.40 M
ASND annual total operating expenses is $647.40 million

Annual Cost Of Goods Sold

$47.90 M
ASND annual cost of goods sold is $47.90 million

ASND Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.9%+5.0%-
3 y3 years+62.5%+5.0%-
5 y5 years+467.5%+5.0%-

ASND Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+62.5%at high+60.5%
5 y5-yearat high+467.5%at high+344.1%
alltimeall timeat high+9498.2%at high>+9999.0%

Ascendis Pharma A/S Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$307.98 M(+9.9%)
$83.98 M(+12.1%)
$311.46 M(+5.8%)
Sep 2024
-
$74.93 M(-6.4%)
$294.39 M(+2.4%)
Jun 2024
-
$80.02 M(+10.3%)
$287.52 M(+1.2%)
Mar 2024
-
$72.54 M(+8.4%)
$284.14 M(+0.4%)
Dec 2023
$280.17 M(+23.1%)
$66.90 M(-1.7%)
$283.07 M(+5.4%)
Sep 2023
-
$68.06 M(-11.2%)
$268.49 M(+2.7%)
Jun 2023
-
$76.64 M(+7.2%)
$261.55 M(+6.7%)
Mar 2023
-
$71.47 M(+36.6%)
$245.18 M(+8.0%)
Dec 2022
$227.63 M(+20.1%)
$52.33 M(-14.4%)
$226.93 M(-1.3%)
Sep 2022
-
$61.12 M(+1.4%)
$229.84 M(+6.9%)
Jun 2022
-
$60.27 M(+13.3%)
$215.04 M(+9.0%)
Mar 2022
-
$53.21 M(-3.7%)
$197.37 M(+4.4%)
Dec 2021
$189.52 M(+116.5%)
$55.25 M(+19.3%)
$189.04 M(+19.5%)
Sep 2021
-
$46.32 M(+8.7%)
$158.15 M(+19.5%)
Jun 2021
-
$42.60 M(-5.1%)
$132.33 M(+17.5%)
Mar 2021
-
$44.88 M(+84.3%)
$112.64 M(+28.7%)
Dec 2020
$87.56 M(+61.4%)
$24.35 M(+18.8%)
$87.53 M(+6.6%)
Sep 2020
-
$20.49 M(-10.6%)
$82.08 M(+12.9%)
Jun 2020
-
$22.91 M(+15.9%)
$72.71 M(+17.1%)
Mar 2020
-
$19.77 M(+4.5%)
$62.11 M(+14.6%)
Dec 2019
$54.27 M
$18.91 M(+70.1%)
$54.20 M(+20.9%)
Sep 2019
-
$11.12 M(-9.7%)
$44.84 M(+7.7%)
Jun 2019
-
$12.31 M(+3.9%)
$41.62 M(+17.1%)
DateAnnualQuarterlyTTM
Mar 2019
-
$11.85 M(+24.1%)
$35.55 M(+20.8%)
Dec 2018
$29.59 M(+93.8%)
$9.55 M(+20.9%)
$29.42 M(+19.2%)
Sep 2018
-
$7.90 M(+26.6%)
$24.68 M(+22.7%)
Jun 2018
-
$6.24 M(+9.0%)
$20.12 M(+15.4%)
Mar 2018
-
$5.73 M(+19.0%)
$17.43 M(+14.3%)
Dec 2017
$15.27 M(+19.9%)
$4.81 M(+44.1%)
$15.25 M(+9.1%)
Sep 2017
-
$3.34 M(-6.1%)
$13.98 M(+2.9%)
Jun 2017
-
$3.56 M(+0.4%)
$13.59 M(+4.1%)
Mar 2017
-
$3.54 M(-0.1%)
$13.05 M(+2.6%)
Dec 2016
$12.73 M(+21.9%)
$3.54 M(+20.3%)
$12.72 M(-1.9%)
Sep 2016
-
$2.95 M(-2.2%)
$12.97 M(+12.1%)
Jun 2016
-
$3.02 M(-6.0%)
$11.57 M(+5.9%)
Mar 2016
-
$3.21 M(-15.5%)
$10.93 M(+4.7%)
Dec 2015
$10.45 M(+25.2%)
$3.80 M(+144.7%)
$10.43 M(+8.8%)
Sep 2015
-
$1.55 M(-34.5%)
$9.59 M(-5.1%)
Jun 2015
-
$2.37 M(-12.7%)
$10.10 M(+4.5%)
Mar 2015
-
$2.71 M(-8.2%)
$9.66 M(+17.2%)
Dec 2014
$8.34 M(+160.0%)
$2.95 M(+43.3%)
$8.24 M(+36.5%)
Sep 2014
-
$2.06 M(+6.9%)
$6.04 M(+51.9%)
Jun 2014
-
$1.93 M(+49.1%)
$3.98 M(+94.3%)
Mar 2014
-
$1.29 M(+72.3%)
$2.05 M(+172.3%)
Dec 2013
$3.21 M(-7.2%)
$751.40 K
$751.40 K
Dec 2012
$3.46 M
-
-

FAQ

  • What is Ascendis Pharma A/S annual SGA?
  • What is the all time high annual SGA for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S annual SGA year-on-year change?
  • What is Ascendis Pharma A/S quarterly SGA?
  • What is the all time high quarterly SGA for Ascendis Pharma A/S?
  • What is Ascendis Pharma A/S quarterly SGA year-on-year change?
  • What is the all time high TTM SGA for Ascendis Pharma A/S?

What is Ascendis Pharma A/S annual SGA?

The current annual SGA of ASND is $307.98 M

What is the all time high annual SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high annual SGA is $307.98 M

What is Ascendis Pharma A/S annual SGA year-on-year change?

Over the past year, ASND annual SGA has changed by +$27.81 M (+9.93%)

What is Ascendis Pharma A/S quarterly SGA?

The current quarterly SGA of ASND is $83.98 M

What is the all time high quarterly SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high quarterly SGA is $83.98 M

What is Ascendis Pharma A/S quarterly SGA year-on-year change?

Over the past year, ASND quarterly SGA has changed by +$3.96 M (+4.95%)

What is the all time high TTM SGA for Ascendis Pharma A/S?

Ascendis Pharma A/S all-time high TTM SGA is $556.61 M